Federal obligations in biotechnology R&D (NAICS 541711)

Why NAICS 541711 still appears

NAICS 541711 was the biotechnology R&D code before the classification split out nanobiotechnology on 541714. USAspending.gov still shows contract awards tagged 541711 because older vehicles, modifications, and some current coding continue to use it. The $18.3 billion figure is the obligation stock on those tagged awards, not a Census survey of biotech firms and not a count of licensed products.

541714 is biotechnology R&D except nanobiotechnology and, in this industry set, carries more award records. Physical-sciences R&D codes (541710, 541712, 541715) except or omit biotech by title. Biological-product manufacturing (325414) is production, not this research line. Do not add 541711 to 541714 as one industry without checking how awards were tagged.

473 awards and $18.3 billion

The 473 award count is extremely concentrated. Large, long-lived biotech research contracts and lingering use of a legacy NAICS code can produce few rows and large dollars. USAspending counts award records, including the way agencies increment and modify them. The count is not 473 laboratories.

Obligations are commitments. This packet has no fiscal-year split and no outlay total. Quote $18,258,755,045.17 as USAspending contract obligations coded to NAICS 541711. Do not describe it as the NIH budget, as grants, or as cash already spent.

Contract R&D versus grants and manufacturing

A large share of federal biomedical dollars moves as assistance. Assistance awards often have no NAICS, so they do not roll into this industry total. University grants that look like the same science as a 541711 contract will not appear here unless they are contract awards tagged with this code. Manufacturing of biological products is 325414, a different table.

A 473-award industry with $18,258,755,045.17 in obligations is telling you to look for large vehicles and sticky tags, not for a census of biotech firms. That is NAICS 541711 on USAspending: research and development in biotechnology, the older combined line. 541714 is the later split with an except-nanobiotechnology clause and a different award count on its own page. Do not merge them. Do not merge manufacturing (325414). Do not merge physical-sciences R&D. Grants often have no NAICS. The 473 records are contract actions, including modifications that keep an old code alive. This page is not medical advice. Quote obligations, not outlays. Use the industry table for the short list of rows.

What this table is not

It is not 541714. It is not pharmaceutical preparation manufacturing (325412). It is not social-science R&D (541720). It is not a pipeline of drugs in development. Agencies and recipients that perform biotech work under other NAICS lines have their dollars on those pages.

SpendingVault aggregates USAspending.gov contract awards. The 473 count and the dollar total can change after corrections. Use the live industry page as the current table.

Using the 541711 industry page

Open the RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY industry page for the award list under the headline. Compare 541711 with 541714 and with 325414 on All industries, and keep the codes distinct. Cite obligations, not outlays, and keep the 473 award count so readers see how concentrated this vintage biotech code is.

Citing a concentrated legacy biotech R&D code

Cite $18,258,755,045.17 in USAspending obligations on 473 awards tagged NAICS 541711, research and development in biotechnology. Put 473 next to the dollars. That small record count is the difference from later split codes and from high-volume services lines.

Do not add 541714. Do not add 325414 manufacturing. Do not call the figure grants. Assistance often has no NAICS. Outlays are not in the packet. This page is not medical advice. The industry table is the award list; this guide restates packet facts only.

541711 is the sticky older biotech-research code. The $18,258,755,045.17 total on 473 awards is the signature of a few large vehicles still carrying that tag, plus whatever current awards still use it. That is a hypothesis consistent with the count, not a dating of the file; this packet has no award-year split. It is a reason to keep 541711 on its own page.

Do not merge with 541714. Do not merge with 325414 manufacturing. Do not merge with physical-sciences R&D. Grants often have no NAICS. This page is not medical advice. Cite USAspending obligations on 473 awards coded 541711, research and development in biotechnology. Keep outlays out. The industry table is the list behind the concentrated total.

Questions

How much is obligated on NAICS 541711 biotechnology R&D?

USAspending.gov contract awards coded NAICS 541711 show $18,258,755,045.17 in obligations across 473 awards. That total is obligations, not outlays, for the biotechnology R&D code 541711. USAspending.gov records the amount as contract obligations, not outlays, on awards tagged NAICS 541711.

Is 541711 the same as 541714?

No. 541711 is the older biotechnology R&D line. 541714 is biotechnology R&D except nanobiotechnology. This page reports only $18,258,755,045.17 on 541711. Do not merge the codes. The packet total is $18,258,755,045.17 across 473 awards; assistance awards often have no NAICS and stay outside the industry rollup.

Why are there only 473 awards?

The 473 figure counts contract award records coded to 541711. Large, long-lived vehicles and lingering use of a legacy NAICS code can produce few rows and large dollars. It is not a count of laboratories or grants. Treat the 473 figure as an award-record count, including orders and modifications, not as a physical inventory of products or sites.

Are NIH grants or vaccine purchases included?

Assistance awards may not carry NAICS and are generally outside this total. Vaccine manufacturing is NAICS 325414. The $18,258,755,045.17 figure is contract obligations tagged 541711 only. This guide does not add a fiscal-year split. Quote the live industry page if you need the current award list under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY.